Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Differences in study duration and patient populations complicate direct comparison, but the mechanistic rationale and sheer magnitude of effect strongly favor Retatrutide for monotherapy applications
Semaglutide (2.4 mg/week), approved in 2021, delivers improved weight loss compared to the earlier treatments and represents considerable progress in obesity pharmacotherapy (13)
Physical Activity: The Best Medicine for Insulin Resistance A recent study found that exercising 150 minutes or more a week increased the likelihood of reversing prediabetes
A Retatrutide dose escalation schedule can be adjusted at any point if a provider identifies side effects, health changes, or other factors that warrant a different pace
US$ 27.63
US$ 25.76
US$ 22.81
US$ 29.22
US$ 26.64
US$ 29.82
US$ 26.33
